nodes	percent_of_prediction	percent_of_DWPC	metapath
Lucanthone—TOP1—lung cancer	0.419	1	CbGaD
Lucanthone—TOP1—Topotecan—lung cancer	0.249	0.531	CbGbCtD
Lucanthone—TOP1—Irinotecan—lung cancer	0.122	0.259	CbGbCtD
Lucanthone—TOP2A—Teniposide—lung cancer	0.0564	0.12	CbGbCtD
Lucanthone—TOP2A—Etoposide—lung cancer	0.0249	0.0531	CbGbCtD
Lucanthone—TOP2A—Doxorubicin—lung cancer	0.017	0.0362	CbGbCtD
Lucanthone—APEX1—mammary gland—lung cancer	0.00415	0.126	CbGeAlD
Lucanthone—TOP1—mammary gland—lung cancer	0.0029	0.0884	CbGeAlD
Lucanthone—APEX1—respiratory system—lung cancer	0.00276	0.0842	CbGeAlD
Lucanthone—APEX1—epithelium—lung cancer	0.00231	0.0703	CbGeAlD
Lucanthone—APEX1—bronchus—lung cancer	0.00227	0.0693	CbGeAlD
Lucanthone—APEX1—trachea—lung cancer	0.00204	0.0622	CbGeAlD
Lucanthone—APEX1—cardiac atrium—lung cancer	0.00192	0.0584	CbGeAlD
Lucanthone—APEX1—bone marrow—lung cancer	0.00162	0.0493	CbGeAlD
Lucanthone—TOP1—bronchus—lung cancer	0.00159	0.0485	CbGeAlD
Lucanthone—APEX1—lung—lung cancer	0.00147	0.0447	CbGeAlD
Lucanthone—TOP1—trachea—lung cancer	0.00143	0.0435	CbGeAlD
Lucanthone—TOP1—cardiac atrium—lung cancer	0.00134	0.0409	CbGeAlD
Lucanthone—TOP1—bone marrow—lung cancer	0.00113	0.0345	CbGeAlD
Lucanthone—TOP2A—bronchus—lung cancer	0.00113	0.0345	CbGeAlD
Lucanthone—APEX1—Base Excision Repair—SMUG1—lung cancer	0.00107	0.0142	CbGpPWpGaD
Lucanthone—TOP1—lung—lung cancer	0.00103	0.0313	CbGeAlD
Lucanthone—APEX1—Global Genomic NER (GG-NER)—ERCC1—lung cancer	0.00101	0.0134	CbGpPWpGaD
Lucanthone—APEX1—lymph node—lung cancer	0.001	0.0306	CbGeAlD
Lucanthone—APEX1—Spinal Cord Injury—ROS1—lung cancer	0.000954	0.0127	CbGpPWpGaD
Lucanthone—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—RRAD—lung cancer	0.000921	0.0123	CbGpPWpGaD
Lucanthone—APEX1—HIF-2-alpha transcription factor network—ABCG2—lung cancer	0.000874	0.0116	CbGpPWpGaD
Lucanthone—TOP2A—bone marrow—lung cancer	0.000806	0.0246	CbGeAlD
Lucanthone—APEX1—Transcription-coupled NER (TC-NER)—ERCC1—lung cancer	0.000805	0.0107	CbGpPWpGaD
Lucanthone—TOP1—Caspase Cascade in Apoptosis—LMNA—lung cancer	0.000796	0.0106	CbGpPWpGaD
Lucanthone—APEX1—Nucleotide Excision Repair—ERCC1—lung cancer	0.00074	0.00985	CbGpPWpGaD
Lucanthone—APEX1—HIF-2-alpha transcription factor network—FLT1—lung cancer	0.00074	0.00984	CbGpPWpGaD
Lucanthone—TOP2A—lung—lung cancer	0.000731	0.0223	CbGeAlD
Lucanthone—APEX1—DNA Repair—MSH3—lung cancer	0.000714	0.0095	CbGpPWpGaD
Lucanthone—TOP1—Caspase Cascade in Apoptosis—APP—lung cancer	0.000709	0.00944	CbGpPWpGaD
Lucanthone—TOP1—lymph node—lung cancer	0.000702	0.0214	CbGeAlD
Lucanthone—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—AXL—lung cancer	0.000698	0.00929	CbGpPWpGaD
Lucanthone—APEX1—DNA Repair—XPC—lung cancer	0.000685	0.00911	CbGpPWpGaD
Lucanthone—TOP1—Circadian rythm related genes—KMT2A—lung cancer	0.000594	0.00791	CbGpPWpGaD
Lucanthone—APEX1—Extension of Telomeres—TERT—lung cancer	0.00053	0.00705	CbGpPWpGaD
Lucanthone—TOP1—Circadian rythm related genes—NKX2-1—lung cancer	0.00053	0.00705	CbGpPWpGaD
Lucanthone—APEX1—Spinal Cord Injury—SLIT2—lung cancer	0.000501	0.00667	CbGpPWpGaD
Lucanthone—TOP2A—lymph node—lung cancer	0.0005	0.0152	CbGeAlD
Lucanthone—APEX1—Global Genomic NER (GG-NER)—ERCC2—lung cancer	0.000498	0.00662	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—RHEB—lung cancer	0.000495	0.00659	CbGpPWpGaD
Lucanthone—TOP1—Caspase Cascade in Apoptosis—FASLG—lung cancer	0.000482	0.00641	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—NODAL—lung cancer	0.000469	0.00624	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—RRM1—lung cancer	0.000469	0.00624	CbGpPWpGaD
Lucanthone—TOP1—Caspase Cascade in Apoptosis—BCL2L1—lung cancer	0.000439	0.00584	CbGpPWpGaD
Lucanthone—APEX1—DNA Repair—MSH6—lung cancer	0.00043	0.00572	CbGpPWpGaD
Lucanthone—APEX1—HIF-2-alpha transcription factor network—KDR—lung cancer	0.000427	0.00568	CbGpPWpGaD
Lucanthone—APEX1—Transcription-coupled NER (TC-NER)—ERCC2—lung cancer	0.000398	0.00529	CbGpPWpGaD
Lucanthone—APEX1—DNA Repair—XRCC1—lung cancer	0.000393	0.00523	CbGpPWpGaD
Lucanthone—Amiodarone—CYP2A6—lung cancer	0.000392	0.327	CrCbGaD
Lucanthone—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—TP63—lung cancer	0.000387	0.00515	CbGpPWpGaD
Lucanthone—APEX1—DNA Repair—ERCC1—lung cancer	0.000386	0.00513	CbGpPWpGaD
Lucanthone—APEX1—Nucleotide Excision Repair—ERCC2—lung cancer	0.000366	0.00487	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—RARB—lung cancer	0.000365	0.00486	CbGpPWpGaD
Lucanthone—APEX1—HIF-2-alpha transcription factor network—CREBBP—lung cancer	0.000364	0.00485	CbGpPWpGaD
Lucanthone—TOP2A—Retinoblastoma (RB) in Cancer—HMGB2—lung cancer	0.000363	0.00483	CbGpPWpGaD
Lucanthone—TOP1—Caspase Cascade in Apoptosis—CASP8—lung cancer	0.000359	0.00477	CbGpPWpGaD
Lucanthone—TOP1—Circadian rythm related genes—AHR—lung cancer	0.00035	0.00466	CbGpPWpGaD
Lucanthone—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—SFN—lung cancer	0.00033	0.0044	CbGpPWpGaD
Lucanthone—APEX1—DNA Repair—OGG1—lung cancer	0.000328	0.00436	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—HPGDS—lung cancer	0.000319	0.00424	CbGpPWpGaD
Lucanthone—APEX1—TSH signaling pathway—IGF1R—lung cancer	0.000319	0.00424	CbGpPWpGaD
Lucanthone—TOP1—Circadian rythm related genes—ADCY1—lung cancer	0.000312	0.00416	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—ANXA1—lung cancer	0.000284	0.00378	CbGpPWpGaD
Lucanthone—APEX1—Spinal Cord Injury—ANXA1—lung cancer	0.000282	0.00376	CbGpPWpGaD
Lucanthone—TOP2A—Retinoblastoma (RB) in Cancer—RRM1—lung cancer	0.000275	0.00366	CbGpPWpGaD
Lucanthone—Amiodarone—CYP1A1—lung cancer	0.000275	0.229	CrCbGaD
Lucanthone—TOP1—Caspase Cascade in Apoptosis—CASP3—lung cancer	0.000271	0.00361	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—APP—lung cancer	0.000269	0.00359	CbGpPWpGaD
Lucanthone—APEX1—DNA Repair—SMUG1—lung cancer	0.000256	0.00341	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—JUNB—lung cancer	0.000255	0.0034	CbGpPWpGaD
Lucanthone—TOP2A—Docetaxel—Paclitaxel—lung cancer	0.000254	0.0888	CbGdCrCtD
Lucanthone—APEX1—HIF-2-alpha transcription factor network—EP300—lung cancer	0.000248	0.0033	CbGpPWpGaD
Lucanthone—TOP2A—Retinoblastoma (RB) in Cancer—MSH6—lung cancer	0.000245	0.00326	CbGpPWpGaD
Lucanthone—APEX1—Epirubicin—Doxorubicin—lung cancer	0.000243	0.085	CbGdCrCtD
Lucanthone—APEX1—Telomere Maintenance—TERT—lung cancer	0.00024	0.0032	CbGpPWpGaD
Lucanthone—APEX1—HIF-2-alpha transcription factor network—VEGFA—lung cancer	0.000235	0.00313	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—STK11—lung cancer	0.000232	0.00308	CbGpPWpGaD
Lucanthone—APEX1—Spinal Cord Injury—FOXO3—lung cancer	0.000222	0.00296	CbGpPWpGaD
Lucanthone—APEX1—TSH signaling pathway—BRAF—lung cancer	0.000217	0.00289	CbGpPWpGaD
Lucanthone—TOP2A—Irinotecan—Topotecan—lung cancer	0.000217	0.076	CbGdCrCtD
Lucanthone—APEX1—TSH signaling pathway—RB1—lung cancer	0.000214	0.00284	CbGpPWpGaD
Lucanthone—TOP2A—Gastric Cancer Network 1—APC—lung cancer	0.000206	0.00275	CbGpPWpGaD
Lucanthone—APEX1—TSH signaling pathway—MAP2K1—lung cancer	0.000205	0.00272	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—ABCB1—lung cancer	0.000203	0.0027	CbGpPWpGaD
Lucanthone—TOP1—Circadian rythm related genes—AVP—lung cancer	0.000201	0.00268	CbGpPWpGaD
Lucanthone—APEX1—Chromosome Maintenance—TERT—lung cancer	0.0002	0.00266	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—TYMS—lung cancer	0.000199	0.00265	CbGpPWpGaD
Lucanthone—TOP1—Circadian rythm related genes—TYMS—lung cancer	0.000191	0.00255	CbGpPWpGaD
Lucanthone—APEX1—DNA Repair—ERCC2—lung cancer	0.00019	0.00253	CbGpPWpGaD
Lucanthone—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—HES1—lung cancer	0.00019	0.00253	CbGpPWpGaD
Lucanthone—TOP2A—Erlotinib—Gefitinib—lung cancer	0.00019	0.0663	CbGdCrCtD
Lucanthone—Flurazepam—CYP2A6—lung cancer	0.000186	0.155	CrCbGaD
Lucanthone—TOP2A—Circadian rythm related genes—KMT2A—lung cancer	0.000186	0.00247	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—FASLG—lung cancer	0.000183	0.00244	CbGpPWpGaD
Lucanthone—APEX1—TSH signaling pathway—RAF1—lung cancer	0.000181	0.00242	CbGpPWpGaD
Lucanthone—TOP2A—Topotecan—Irinotecan—lung cancer	0.000181	0.0631	CbGdCrCtD
Lucanthone—TOP2A—Etoposide—Teniposide—lung cancer	0.000179	0.0627	CbGdCrCtD
Lucanthone—APEX1—TSH signaling pathway—MTOR—lung cancer	0.000177	0.00236	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—TOP1—lung cancer	0.000177	0.00235	CbGpPWpGaD
Lucanthone—TOP2A—Circadian rythm related genes—TOP1—lung cancer	0.00017	0.00226	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—FGFR1—lung cancer	0.000169	0.00224	CbGpPWpGaD
Lucanthone—TOP2A—Circadian rythm related genes—NKX2-1—lung cancer	0.000165	0.0022	CbGpPWpGaD
Lucanthone—TOP2A—Vindesine—Vinorelbine—lung cancer	0.000161	0.0565	CbGdCrCtD
Lucanthone—APEX1—TSH signaling pathway—JUN—lung cancer	0.000158	0.00211	CbGpPWpGaD
Lucanthone—APEX1—Synthesis of DNA—RB1—lung cancer	0.000158	0.00211	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—RHEB—lung cancer	0.000155	0.00206	CbGpPWpGaD
Lucanthone—APEX1—DNA Replication—RB1—lung cancer	0.000148	0.00198	CbGpPWpGaD
Lucanthone—TOP1—Caspase Cascade in Apoptosis—AKT1—lung cancer	0.000147	0.00195	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—NODAL—lung cancer	0.000147	0.00195	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—RRM1—lung cancer	0.000147	0.00195	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—APC—lung cancer	0.000146	0.00195	CbGpPWpGaD
Lucanthone—Amiodarone—ABCB1—lung cancer	0.000146	0.122	CrCbGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—EGF—lung cancer	0.000145	0.00192	CbGpPWpGaD
Lucanthone—APEX1—TSH signaling pathway—SRC—lung cancer	0.000142	0.00189	CbGpPWpGaD
Lucanthone—APEX1—TSH signaling pathway—STAT3—lung cancer	0.000137	0.00182	CbGpPWpGaD
Lucanthone—TOP2A—Podofilox—Teniposide—lung cancer	0.000137	0.0479	CbGdCrCtD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—CASP8—lung cancer	0.000136	0.00181	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—CREBBP—lung cancer	0.000136	0.00181	CbGpPWpGaD
Lucanthone—APEX1—Spinal Cord Injury—RB1—lung cancer	0.000134	0.00179	CbGpPWpGaD
Lucanthone—Flurazepam—CYP2E1—lung cancer	0.000132	0.11	CrCbGaD
Lucanthone—APEX1—TSH signaling pathway—MAPK3—lung cancer	0.000131	0.00174	CbGpPWpGaD
Lucanthone—TOP2A—Mitotic G1-G1/S phases—PPP2R1B—lung cancer	0.000131	0.00174	CbGpPWpGaD
Lucanthone—APEX1—S Phase—RB1—lung cancer	0.00013	0.00173	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—MAP2K1—lung cancer	0.000129	0.00172	CbGpPWpGaD
Lucanthone—TOP2A—Vindesine—Vinblastine—lung cancer	0.000129	0.0451	CbGdCrCtD
Lucanthone—TOP2A—Methotrexate—Pemetrexed—lung cancer	0.000129	0.045	CbGdCrCtD
Lucanthone—APEX1—TSH signaling pathway—MYC—lung cancer	0.000127	0.00169	CbGpPWpGaD
Lucanthone—TOP2A—Paclitaxel—Docetaxel—lung cancer	0.000127	0.0443	CbGdCrCtD
Lucanthone—APEX1—Cell Cycle, Mitotic—FOXM1—lung cancer	0.000125	0.00166	CbGpPWpGaD
Lucanthone—TOP2A—Afatinib—Gefitinib—lung cancer	0.000124	0.0434	CbGdCrCtD
Lucanthone—TOP2A—Gefitinib—Erlotinib—lung cancer	0.000122	0.0425	CbGdCrCtD
Lucanthone—TOP2A—Retinoblastoma (RB) in Cancer—TYMS—lung cancer	0.000117	0.00155	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—MDM2—lung cancer	0.000115	0.00153	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—RAF1—lung cancer	0.000115	0.00153	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—RARB—lung cancer	0.000114	0.00152	CbGpPWpGaD
Lucanthone—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—CDKN2A—lung cancer	0.000114	0.00152	CbGpPWpGaD
Lucanthone—APEX1—Synthesis of DNA—CDKN1A—lung cancer	0.000114	0.00151	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—ERBB2—lung cancer	0.000114	0.00151	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—FOXM1—lung cancer	0.000112	0.00149	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—PTGS2—lung cancer	0.000111	0.00148	CbGpPWpGaD
Lucanthone—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—MDM2—lung cancer	0.000111	0.00147	CbGpPWpGaD
Lucanthone—APEX1—Spinal Cord Injury—PTGS2—lung cancer	0.00011	0.00147	CbGpPWpGaD
Lucanthone—TOP2A—Circadian rythm related genes—AHR—lung cancer	0.000109	0.00146	CbGpPWpGaD
Lucanthone—APEX1—TSH signaling pathway—PIK3CA—lung cancer	0.000108	0.00144	CbGpPWpGaD
Lucanthone—TOP2A—Gastric Cancer Network 2—MYC—lung cancer	0.000108	0.00143	CbGpPWpGaD
Lucanthone—APEX1—Spinal Cord Injury—CXCL8—lung cancer	0.000107	0.00142	CbGpPWpGaD
Lucanthone—APEX1—DNA Replication—CDKN1A—lung cancer	0.000107	0.00142	CbGpPWpGaD
Lucanthone—TOP2A—Gastric Cancer Network 2—EGFR—lung cancer	0.000105	0.0014	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle, Mitotic—PPP2R1B—lung cancer	0.000104	0.00138	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—CASP3—lung cancer	0.000103	0.00137	CbGpPWpGaD
Lucanthone—APEX1—Spinal Cord Injury—CASP3—lung cancer	0.000102	0.00136	CbGpPWpGaD
Lucanthone—APEX1—Spinal Cord Injury—IL2—lung cancer	0.000102	0.00136	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—CCND1—lung cancer	0.0001	0.00134	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—JUN—lung cancer	0.0001	0.00133	CbGpPWpGaD
Lucanthone—APEX1—TSH signaling pathway—HRAS—lung cancer	9.99e-05	0.00133	CbGpPWpGaD
Lucanthone—APEX1—Spinal Cord Injury—CCND1—lung cancer	9.97e-05	0.00133	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—HPGDS—lung cancer	9.96e-05	0.00133	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle, Mitotic—LMNA—lung cancer	9.89e-05	0.00132	CbGpPWpGaD
Lucanthone—TOP2A—Circadian rythm related genes—ADCY1—lung cancer	9.75e-05	0.0013	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—CDKN1A—lung cancer	9.71e-05	0.00129	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—PTEN—lung cancer	9.69e-05	0.00129	CbGpPWpGaD
Lucanthone—APEX1—Spinal Cord Injury—MMP9—lung cancer	9.68e-05	0.00129	CbGpPWpGaD
Lucanthone—APEX1—S Phase—CCND1—lung cancer	9.64e-05	0.00128	CbGpPWpGaD
Lucanthone—TOP1—Circadian rythm related genes—JUN—lung cancer	9.62e-05	0.00128	CbGpPWpGaD
Lucanthone—APEX1—S Phase—CDKN1A—lung cancer	9.33e-05	0.00124	CbGpPWpGaD
Lucanthone—TOP1—Circadian rythm related genes—PTEN—lung cancer	9.3e-05	0.00124	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—PPP2R1B—lung cancer	9.27e-05	0.00123	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—EP300—lung cancer	9.24e-05	0.00123	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—SRC—lung cancer	8.98e-05	0.0012	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—ANXA1—lung cancer	8.88e-05	0.00118	CbGpPWpGaD
Lucanthone—TOP1—Circadian rythm related genes—EP300—lung cancer	8.87e-05	0.00118	CbGpPWpGaD
Lucanthone—TOP2A—Gastric Cancer Network 2—TP53—lung cancer	8.85e-05	0.00118	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—LMNA—lung cancer	8.84e-05	0.00118	CbGpPWpGaD
Lucanthone—APEX1—TSH signaling pathway—AKT1—lung cancer	8.82e-05	0.00117	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—VEGFA—lung cancer	8.75e-05	0.00116	CbGpPWpGaD
Lucanthone—TOP2A—Vincristine—Vinorelbine—lung cancer	8.71e-05	0.0305	CbGdCrCtD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—APP—lung cancer	8.42e-05	0.00112	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—MAPK3—lung cancer	8.28e-05	0.0011	CbGpPWpGaD
Lucanthone—TOP2A—Mitotic G1-G1/S phases—TYMS—lung cancer	8.22e-05	0.00109	CbGpPWpGaD
Lucanthone—APEX1—Spinal Cord Injury—MAPK3—lung cancer	8.22e-05	0.00109	CbGpPWpGaD
Lucanthone—TOP2A—Vinorelbine—Vinblastine—lung cancer	8.15e-05	0.0285	CbGdCrCtD
Lucanthone—TOP2A—Podofilox—Etoposide—lung cancer	8.14e-05	0.0285	CbGdCrCtD
Lucanthone—TOP2A—Teniposide—Etoposide—lung cancer	8.14e-05	0.0285	CbGdCrCtD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—MYC—lung cancer	8.05e-05	0.00107	CbGpPWpGaD
Lucanthone—APEX1—Spinal Cord Injury—MYC—lung cancer	7.99e-05	0.00106	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—JUNB—lung cancer	7.97e-05	0.00106	CbGpPWpGaD
Lucanthone—TOP2A—Retinoblastoma (RB) in Cancer—RB1—lung cancer	7.92e-05	0.00105	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—EGFR—lung cancer	7.87e-05	0.00105	CbGpPWpGaD
Lucanthone—APEX1—Spinal Cord Injury—EGFR—lung cancer	7.82e-05	0.00104	CbGpPWpGaD
Lucanthone—APEX1—S Phase—MYC—lung cancer	7.73e-05	0.00103	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—KRAS—lung cancer	7.44e-05	0.00099	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—STK11—lung cancer	7.24e-05	0.000963	CbGpPWpGaD
Lucanthone—TOP2A—Vinblastine—Vinorelbine—lung cancer	7.01e-05	0.0245	CbGdCrCtD
Lucanthone—TOP2A—Vincristine—Vinblastine—lung cancer	6.97e-05	0.0244	CbGdCrCtD
Lucanthone—Flurazepam—ABCB1—lung cancer	6.92e-05	0.0576	CrCbGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—PIK3CA—lung cancer	6.83e-05	0.00091	CbGpPWpGaD
Lucanthone—TOP2A—Retinoblastoma (RB) in Cancer—MDM2—lung cancer	6.75e-05	0.000899	CbGpPWpGaD
Lucanthone—TOP2A—Retinoblastoma (RB) in Cancer—RAF1—lung cancer	6.73e-05	0.000896	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—TP53—lung cancer	6.61e-05	0.00088	CbGpPWpGaD
Lucanthone—APEX1—Spinal Cord Injury—TP53—lung cancer	6.57e-05	0.000874	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle, Mitotic—TYMS—lung cancer	6.52e-05	0.000867	CbGpPWpGaD
Lucanthone—TOP1—Circadian rythm related genes—TP53—lung cancer	6.35e-05	0.000845	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—ABCB1—lung cancer	6.34e-05	0.000844	CbGpPWpGaD
Lucanthone—TOP2A—Circadian rythm related genes—AVP—lung cancer	6.29e-05	0.000836	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—TYMS—lung cancer	6.23e-05	0.000829	CbGpPWpGaD
Lucanthone—APEX1—Spinal Cord Injury—IL6—lung cancer	6.01e-05	0.0008	CbGpPWpGaD
Lucanthone—TOP2A—Circadian rythm related genes—TYMS—lung cancer	5.98e-05	0.000796	CbGpPWpGaD
Lucanthone—TOP2A—Retinoblastoma (RB) in Cancer—CCND1—lung cancer	5.88e-05	0.000783	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle, Mitotic—BIRC5—lung cancer	5.86e-05	0.00078	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—TYMS—lung cancer	5.83e-05	0.000776	CbGpPWpGaD
Lucanthone—TOP1—Circadian rythm related genes—IL6—lung cancer	5.81e-05	0.000773	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle, Mitotic—FOXM1—lung cancer	5.78e-05	0.00077	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—FASLG—lung cancer	5.72e-05	0.000762	CbGpPWpGaD
Lucanthone—TOP2A—Retinoblastoma (RB) in Cancer—CDKN1A—lung cancer	5.69e-05	0.000757	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—AKT1—lung cancer	5.58e-05	0.000743	CbGpPWpGaD
Lucanthone—TOP2A—Mitotic G1-G1/S phases—RB1—lung cancer	5.57e-05	0.000742	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—FGFR1—lung cancer	5.27e-05	0.000701	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—BIRC5—lung cancer	5.24e-05	0.000698	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—FOXM1—lung cancer	5.17e-05	0.000688	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—TERT—lung cancer	5.08e-05	0.000676	CbGpPWpGaD
Lucanthone—TOP2A—Mitotic G1-G1/S phases—CDKN2A—lung cancer	4.9e-05	0.000652	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle, Mitotic—PPP2R1B—lung cancer	4.79e-05	0.000638	CbGpPWpGaD
Lucanthone—TOP2A—Retinoblastoma (RB) in Cancer—MYC—lung cancer	4.72e-05	0.000628	CbGpPWpGaD
Lucanthone—TOP2A—Cytarabine—Gemcitabine—lung cancer	4.58e-05	0.016	CbGdCrCtD
Lucanthone—TOP2A—Cell Cycle, Mitotic—LMNA—lung cancer	4.57e-05	0.000609	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—APC—lung cancer	4.57e-05	0.000608	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—EGF—lung cancer	4.52e-05	0.000601	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle, Mitotic—RB1—lung cancer	4.42e-05	0.000588	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—PPP2R1B—lung cancer	4.29e-05	0.00057	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—CASP8—lung cancer	4.26e-05	0.000567	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—CREBBP—lung cancer	4.24e-05	0.000564	CbGpPWpGaD
Lucanthone—TOP2A—Mitotic G1-G1/S phases—CCND1—lung cancer	4.14e-05	0.000551	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—LMNA—lung cancer	4.09e-05	0.000544	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—MAP2K1—lung cancer	4.04e-05	0.000538	CbGpPWpGaD
Lucanthone—TOP2A—Mitotic G1-G1/S phases—CDKN1A—lung cancer	4e-05	0.000533	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—RB1—lung cancer	3.95e-05	0.000526	CbGpPWpGaD
Lucanthone—TOP2A—Epirubicin—Doxorubicin—lung cancer	3.93e-05	0.0137	CbGdCrCtD
Lucanthone—TOP2A—Daunorubicin—Doxorubicin—lung cancer	3.93e-05	0.0137	CbGdCrCtD
Lucanthone—TOP2A—Idarubicin—Doxorubicin—lung cancer	3.93e-05	0.0137	CbGdCrCtD
Lucanthone—APEX1—Cell Cycle, Mitotic—CDKN2A—lung cancer	3.88e-05	0.000517	CbGpPWpGaD
Lucanthone—TOP2A—Retinoblastoma (RB) in Cancer—TP53—lung cancer	3.87e-05	0.000516	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—MDM2—lung cancer	3.6e-05	0.000479	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—RAF1—lung cancer	3.59e-05	0.000477	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—ERBB2—lung cancer	3.55e-05	0.000472	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—CDKN2A—lung cancer	3.47e-05	0.000462	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—PTGS2—lung cancer	3.47e-05	0.000462	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—MDM2—lung cancer	3.37e-05	0.000448	CbGpPWpGaD
Lucanthone—TOP2A—Mitotic G1-G1/S phases—MYC—lung cancer	3.32e-05	0.000442	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle, Mitotic—CCND1—lung cancer	3.28e-05	0.000437	CbGpPWpGaD
Lucanthone—TOP2A—Azacitidine—Gemcitabine—lung cancer	3.28e-05	0.0115	CbGdCrCtD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—CASP3—lung cancer	3.22e-05	0.000429	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle, Mitotic—CDKN1A—lung cancer	3.18e-05	0.000423	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—CCND1—lung cancer	3.14e-05	0.000417	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—JUN—lung cancer	3.13e-05	0.000416	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—CDKN1A—lung cancer	3.03e-05	0.000404	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—PTEN—lung cancer	3.03e-05	0.000403	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle, Mitotic—EP300—lung cancer	3.02e-05	0.000402	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle, Mitotic—TYMS—lung cancer	3.01e-05	0.000401	CbGpPWpGaD
Lucanthone—TOP2A—Circadian rythm related genes—JUN—lung cancer	3e-05	0.0004	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—CCND1—lung cancer	2.93e-05	0.000391	CbGpPWpGaD
Lucanthone—TOP2A—Circadian rythm related genes—PTEN—lung cancer	2.91e-05	0.000387	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—EP300—lung cancer	2.89e-05	0.000384	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—CDKN1A—lung cancer	2.84e-05	0.000378	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—SRC—lung cancer	2.81e-05	0.000374	CbGpPWpGaD
Lucanthone—TOP2A—Circadian rythm related genes—EP300—lung cancer	2.77e-05	0.000369	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—VEGFA—lung cancer	2.73e-05	0.000364	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle, Mitotic—BIRC5—lung cancer	2.71e-05	0.000361	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle, Mitotic—MAPK3—lung cancer	2.71e-05	0.00036	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—EP300—lung cancer	2.7e-05	0.000359	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—TYMS—lung cancer	2.7e-05	0.000359	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle, Mitotic—MYC—lung cancer	2.63e-05	0.00035	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—MAPK3—lung cancer	2.59e-05	0.000344	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—MYC—lung cancer	2.52e-05	0.000335	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—EGFR—lung cancer	2.46e-05	0.000327	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—BIRC5—lung cancer	2.42e-05	0.000323	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—MAPK3—lung cancer	2.42e-05	0.000322	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—MYC—lung cancer	2.35e-05	0.000313	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—TERT—lung cancer	2.35e-05	0.000313	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—KRAS—lung cancer	2.32e-05	0.000309	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—PIK3CA—lung cancer	2.14e-05	0.000284	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—lung cancer	2.07e-05	0.000275	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle, Mitotic—RB1—lung cancer	2.04e-05	0.000272	CbGpPWpGaD
Lucanthone—TOP2A—Circadian rythm related genes—TP53—lung cancer	1.98e-05	0.000264	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—TP53—lung cancer	1.93e-05	0.000257	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—RB1—lung cancer	1.83e-05	0.000243	CbGpPWpGaD
Lucanthone—TOP2A—Circadian rythm related genes—IL6—lung cancer	1.81e-05	0.000242	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle, Mitotic—CDKN2A—lung cancer	1.8e-05	0.000239	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—AKT1—lung cancer	1.74e-05	0.000232	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—CDKN2A—lung cancer	1.61e-05	0.000214	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—MDM2—lung cancer	1.56e-05	0.000207	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle, Mitotic—CCND1—lung cancer	1.52e-05	0.000202	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle, Mitotic—CDKN1A—lung cancer	1.47e-05	0.000195	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle, Mitotic—EP300—lung cancer	1.4e-05	0.000186	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—CCND1—lung cancer	1.36e-05	0.000181	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—CDKN1A—lung cancer	1.31e-05	0.000175	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle, Mitotic—MAPK3—lung cancer	1.25e-05	0.000167	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—EP300—lung cancer	1.25e-05	0.000166	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle, Mitotic—MYC—lung cancer	1.22e-05	0.000162	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—MAPK3—lung cancer	1.12e-05	0.000149	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—MYC—lung cancer	1.09e-05	0.000145	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—TP53—lung cancer	8.94e-06	0.000119	CbGpPWpGaD
